Food and Drug Administration: FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss Harvard Health Publishing: Understanding New Weight Loss Drugs The New England Journal of Medicine : TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss
La plupart de ces tudes portaient sur des personnes obses ou des personnes ges
Detoxification Study: Glutathione supports liver detoxification by neutralizing toxins and heavy metals
Membranes were blocked in PBS containing 5% fat-free milk powder, 5 mM NaN 3 and 0.1% Tween-20
placebo) Outcome domain (eGFR slope, albuminuria, kidney failure composite, cardiorenal composite, safety) Frequency counts were used to describe the number and proportion of studies per category
They do not establish instructions for self-treatment, and cross-trial comparisons cannot substitute for head-to-head studies